| |
| |
|
| Insider
Information: |
Stonehouse Jon P |
| Relationship: |
Director |
| City: |
Birmingham |
| State: |
AL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,331,856 |
|
|
Indirect Shares
|
40,000 |
|
|
| Direct
Value |
$7,300,650 |
|
|
|
Indirect Value
|
$258,400 |
|
|
| Total
Shares |
1,371,856 |
|
|
| Total
Value |
$7,559,050 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 16.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biocryst Pharmaceuticals Inc |
BCRX |
President & CEO, Direc... |
2024-05-13 |
1,127,770 |
2024-05-13 |
40,000 |
Premium* |
|
|
Bellicum Pharmaceuticals, Inc |
BLCM |
Director |
2023-01-03 |
204,086 |
2018-11-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2018-02-28 |
4 |
D |
$4.97 |
$214,823 |
D/D |
(43,224) |
655,092 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2023-02-01 |
4 |
OE |
$5.45 |
$545,000 |
D/D |
100,000 |
1,108,739 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2024-05-13 |
4 |
B |
$5.55 |
$166,500 |
D/D |
30,000 |
1,127,770 |
2.81 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2018-01-20 |
4 |
D |
$5.59 |
$53,575 |
D/D |
(9,584) |
638,367 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2017-01-20 |
4 |
D |
$5.95 |
$62,903 |
D/D |
(10,572) |
645,418 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2023-12-19 |
4 |
D |
$6.05 |
$85,238 |
D/D |
(14,089) |
1,114,770 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2017-01-01 |
4 |
D |
$6.33 |
$54,406 |
D/D |
(8,595) |
655,990 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2023-12-14 |
4 |
D |
$6.43 |
$87,397 |
D/D |
(13,592) |
1,128,859 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
CEO |
• • – |
2007-07-31 |
4 |
B |
$7.06 |
$17,376 |
D/D |
2,463 |
52,463 |
2.81 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2016-01-20 |
4 |
D |
$7.55 |
$80,211 |
D/D |
(10,624) |
665,702 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2014-01-01 |
4 |
D |
$7.60 |
$65,299 |
D/D |
(8,592) |
504,360 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2014-05-09 |
4 |
D |
$7.70 |
$232,648 |
D/D |
(30,214) |
640,445 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2019-01-01 |
4 |
D |
$8.07 |
$28,794 |
D/D |
(3,568) |
724,106 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2020-12-15 |
4 |
AS |
$8.32 |
$1,117,193 |
D/D |
(134,278) |
784,086 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2018-12-03 |
4 |
AS |
$9.12 |
$729,600 |
D/D |
(80,000) |
727,674 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2007-08-13 |
4 |
AB |
$9.80 |
$71,863 |
D/D |
7,250 |
59,713 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2007-08-14 |
4 |
AB |
$9.86 |
$26,129 |
D/D |
2,650 |
62,363 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2015-03-01 |
4 |
D |
$10.20 |
$52,204 |
D/D |
(5,118) |
650,869 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2016-01-01 |
4 |
D |
$10.32 |
$83,499 |
D/D |
(8,091) |
652,230 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2023-02-01 |
4 |
AS |
$10.38 |
$1,038,000 |
D/D |
(100,000) |
1,008,739 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2022-12-15 |
4 |
AS |
$10.90 |
$153,690 |
D/D |
(14,100) |
887,730 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2015-01-20 |
4 |
D |
$11.17 |
$118,491 |
D/D |
(10,608) |
654,280 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2014-03-01 |
4 |
D |
$11.69 |
$59,829 |
D/D |
(5,118) |
630,242 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2015-07-15 |
4 |
OE |
$11.81 |
$399,981 |
D/D |
33,868 |
684,737 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2015-01-01 |
4 |
D |
$12.16 |
$68,728 |
D/D |
(5,652) |
664,888 |
0 |
- |
|
80 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
